AT1 - Atomo Diagnostics

[ash_1050]

After their belter of a day today (+14.71%) I figured now is as good a time as any to create an AT1 thread.

AT1 primarily produced rapid HIV testing kits, however they've recently pivoted with COVID19 causing havoc and are now ramping up production to churn out as many kits as they can.
AT1 have partnered with French biotech company NG Biotech who produce the covid detection strip, while AT1 supply the testing kit.
As long as Covid kicks on I think there's a huge amount of potential with the company.
Currently holding a stack at $0.42 and have a price prediction of $0.80 by end of 2020.
Let's see how that prediction goes.

 

[Deliverance]

TGA approval looks positive.

 

[ash_1050]

FY19 results to be released on Monday 31st August. Share price has jumped up the last couple of days as it will be good news.

 

[ash_1050]

Well it took 14 months but my prediction is finally starting to pay off, AT1 doing very well with their rapid testing kits and their share price is picking up some serious steam.

Shame I sold out 8 months ago.

 

[Deliverance]

Well it took 14 months but my prediction is finally starting to pay off, AT1 doing very well with their rapid testing kits and their share price is picking up some serious steam.

Shame I sold out 8 months ago.

Hope you didn't buy back in.

 

[ash_1050]

Hope you didn't buy back in.

Thankfully not.

 

[Kwality]

Atomo trying to make some noise:

Australia falling behind on Covid-19 rapid testing schemes

Australia needs to take rapid Covid-19 testing more seriously because it is falling behind in how it manages virus testing according to a leading medical device manufacturer.

www.dailymail.co.uk

Swamped by bs .... reckon I read something in the HUN whilst waiting for a coffee. Cant find it now.

atomo share price - Google Search

 

[Kwality]

The Aus is running with it:

NoCookies | The Australian

www.theaustralian.com.au

The boss of one of Australia’s leading rapid test makers has a simple message for public health authorities.
You need to start planning for more rapid testing now.

John Kelly, the chief executive of ASX-listed medtech Atomo Diagnostics, says Australia needs to catch up with the rest of the world – particularly Europe – when it comes to widespread use of rapid testing and accept that it can play an important role in the Covid healthcare response.
“If the current situation doesn’t make that clear – I’m not sure what would. Rapid testing is one of the key pillars of Covid response,” he says.

“There’s no national rapid test strategy and we’ve been waiting two years for this to happen. I don’t understand why as a nation we are not better prepared,” he says.

Atomo, which develops and commercialises antigen-based tests, has been leading the charge in Australia for wider take-up of rapid tests by government to ease the pressure on the lab-based PCR testing. But talks have so far generated little interest.

At times Atomo has found itself wedged between Canberra and the state governments both saying the other is responsible for pushing rapid tests, leaving Australia with one of the lowest adoption rates in the developed world.